308 related articles for article (PubMed ID: 18226885)
1. Effect of powder processing on performance of fenofibrate formulations.
Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
[TBL] [Abstract][Full Text] [Related]
2. Preparation of ultrafine fenofibrate powder by solidification process from emulsion.
Huang QP; Wang JX; Zhang ZB; Shen ZG; Chen JF; Yun J
Int J Pharm; 2009 Feb; 368(1-2):160-4. PubMed ID: 19010406
[TBL] [Abstract][Full Text] [Related]
3. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
[TBL] [Abstract][Full Text] [Related]
4. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
5. Micronization of gemfibrozil by reactive precipitation process.
Huang QP; Wang JX; Chen GZ; Shen ZG; Chen JF; Yun J
Int J Pharm; 2008 Aug; 360(1-2):58-64. PubMed ID: 18502064
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
7. Effect of milling and sieving on functionality of dry powder inhalation products.
Steckel H; Markefka P; teWierik H; Kammelar R
Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
[TBL] [Abstract][Full Text] [Related]
8. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
Branham ML; Moyo T; Govender T
Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
[TBL] [Abstract][Full Text] [Related]
9. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil.
Ratanabanangkoon P; Guzman H; Almarsson O; Berkovitz D; Tokarcyzk S; Straughn AB; Chen H
Eur J Pharm Sci; 2008 Apr; 33(4-5):351-60. PubMed ID: 18313905
[TBL] [Abstract][Full Text] [Related]
11. The effect of crystal morphology and mill type on milling induced crystal disorder.
Chikhalia V; Forbes RT; Storey RA; Ticehurst M
Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
[TBL] [Abstract][Full Text] [Related]
12. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
13. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying.
de Waard H; Hinrichs WL; Frijlink HW
J Control Release; 2008 Jun; 128(2):179-83. PubMed ID: 18423767
[TBL] [Abstract][Full Text] [Related]
14. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
[TBL] [Abstract][Full Text] [Related]
15. Micronization of atorvastatin calcium by antisolvent precipitation process.
Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
[TBL] [Abstract][Full Text] [Related]
16. Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques.
Vaughn JM; Gao X; Yacaman MJ; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2005 May; 60(1):81-9. PubMed ID: 15848060
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
[TBL] [Abstract][Full Text] [Related]
18. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
Waters LJ; Hussain T; Parkes G; Hanrahan JP; Tobin JM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):936-41. PubMed ID: 23954510
[TBL] [Abstract][Full Text] [Related]
20. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
Karmarkar AB
Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
